The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.88%Dividend Yield

Jun 26

$0.27

Mar 26

$0.31

Dec 25

$0.25

Sep 25

$0.24

Jun 25

$0.27

10Y Growth

7.61%

5Y Growth

10.05%

3Y Growth

11.39%

1Y Growth

4.17%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PJP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares U.S. Pharmaceuticals

IHE

Mkt Cap0

IHE is the iShares U.S. Pharmaceuticals ETF, directly competing with PJP by investing in U.S. pharmaceutical companies.

State Street SPDR S&P Pharmaceuticals

XPH

Mkt Cap0

XPH is the SPDR S&P Pharmaceuticals ETF, offering similar exposure to the pharmaceutical sector as PJP, making it a direct competitor.

Invesco Pharmaceuticals

PJP

Mkt Cap0

PJP is the Invesco Pharmaceuticals ETF, directly competing with itself through different share classes or investment strategies within the pharmaceutical sector.

Fidelity MSCI Health Care Index

FHLC

Mkt Cap0

FHLC is the Fidelity MSCI Health Care Index ETF, competing by covering a broad range of healthcare stocks, including pharmaceuticals.

Vanguard Health Care

VHT

Mkt Cap0

VHT is the Vanguard Health Care ETF, which includes pharmaceutical companies in its portfolio, competing for the same investment dollars.

State Street Health Care Select Sector SPDR

XLV

Mkt Cap0

XLV is the Health Care Select Sector SPDR Fund, competing by offering exposure to healthcare, including pharmaceuticals, in the S&P 500.

VanEck Biotech

BBH

Mkt Cap0

BBH is the VanEck Vectors Biotech ETF, competing by investing in biotech which overlaps with pharmaceuticals, offering an alternative within the sector.

iShares Biotechnology

IBB

Mkt Cap0

IBB is the iShares Biotechnology ETF, a competitor by focusing on biotechnology, a sub-sector of pharmaceuticals, attracting similar investors.

Johnson & Johnson

JNJ

Mkt Cap633.19B

JNJ, Johnson & Johnson, competes as a major pharmaceutical company within many ETFs' portfolios, including PJP, representing direct industry competition.

Pfizer

PFE

Mkt Cap138.61B

PFE, Pfizer Inc, is a direct competitor as a leading pharmaceutical company, influencing the performance of pharmaceutical-focused ETFs like PJP.

Holdings

Regions

Sectors

About

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

CEO

Country

United States

ISIN

US46137V6627

Listings

0 Comments

Share your thoughts

FAQ

What is Invesco Pharmaceuticals stock price today?▼

The current price of PJP is $120.00 USD — it has decreased by -0.83% in the past 24 hours. Watch Invesco Pharmaceuticals stock price performance more closely on the chart.

What is Invesco Pharmaceuticals stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Invesco Pharmaceuticals stocks are traded under the ticker PJP.

Is Invesco Pharmaceuticals stock price growing?▼

PJP stock has risen by +0.92% compared to the previous week, the month change is a +8.54% rise, over the last year Invesco Pharmaceuticals has showed a +47.17% increase.

Does Invesco Pharmaceuticals pay dividends?▼

Yes, PJP dividends are paid quarterly. The last dividend per share was 0.27 USD. As of today, Dividend Yield (FWD)% is 0.88%.

In which sector is Invesco Pharmaceuticals located?▼

Invesco Pharmaceuticals operates in the Other sector.

When did Invesco Pharmaceuticals complete a stock split?▼

Invesco Pharmaceuticals has not had any recent stock splits.